Drug Shortage Report for MYLAN-TADALAFIL
Report ID | 152654 |
Drug Identification Number | 02410664 |
Brand name | MYLAN-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 BL |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2022-05-03 |
Actual start date | 2022-05-03 |
Estimated end date | 2022-07-12 |
Actual end date | 2022-07-11 |
Shortage status | Resolved |
Updated date | 2022-07-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2022-07-12 | French | Compare |
v20 | 2022-07-12 | English | Compare |
v19 | 2022-07-06 | French | Compare |
v18 | 2022-07-06 | English | Compare |
v17 | 2022-06-18 | French | Compare |
v16 | 2022-06-18 | English | Compare |
v15 | 2022-06-09 | French | Compare |
v14 | 2022-06-09 | English | Compare |
v13 | 2022-05-31 | French | Compare |
v12 | 2022-05-31 | English | Compare |
v11 | 2022-05-25 | French | Compare |
v10 | 2022-05-25 | English | Compare |
v9 | 2022-05-09 | French | Compare |
v8 | 2022-05-09 | English | Compare |
v7 | 2022-05-04 | English | Compare |
v6 | 2022-05-03 | French | Compare |
v5 | 2022-05-03 | English | Compare |
v4 | 2022-04-26 | French | Compare |
v3 | 2022-04-26 | English | Compare |
v2 | 2022-01-13 | French | Compare |